Daniel A. Pollyea - Division of Hematology, University of Colorado

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 389 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Venetoclax and Hypomethylating Agents in Octo- and Nonagenarians with Acute Myeloid Leukemia

Ellen Madarang, Jill Lykon,Wei Zhao, Mikkael A. Sekeres,Terrence Bradley,Namrata S. Chandhok,Justin Taylor, Sangeetha Venugopal,Tulay Koru-Sengul,Sunil Girish Iyer, Jason Gilbert,Ryan M. Miller,

Blood Neoplasiapp.100016, (2024)

Cited0Views0Bibtex

Molecular measurable residual disease: staring at red herrings

Amanda C. Winters,Daniel A. Pollyea

HAEMATOLOGICA（2024）

Cited0Views0WOSBibtex

Lysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemia

Mohd Minhajuddin,Amanda Winters, Haobin Ye, Shanshan Pei, Brett Stevens, Austin Gillen, Krysta Engel, Stephanie Gipson, Monica Ransom, Maria Amaya, Anagha Inguva,Maura Gasparetto,

Haematologica (2024)

Cited0Views0WOSBibtex

Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine

Amanda C Winters,Mohd Minhajuddin,Brett M Stevens,Ajay Major,Grace Bosma,Diana Abbott,Nicholas Miltgen,Ji Yuan,Amy L Treece,Bradford J Siegele,Mark D Ewalt,Jonathan A Gutman,

Haematologicano. 6 (2024): 1766-1778

Cited0Views0WOSBibtex

White blood cell count nadir to zero following intensive chemotherapy as a predictive factor for patients with acute myeloid leukemia

Jacob Fang,Grace Bosma,Dara Aisner,Christine McMahon,Maria Amaya,Marc Schwartz,Jeff Kaiser,Diana Abbott,Zenggang Pan,Jeffrey Schowinsky,Changlee Pang,Jonathan A. Gutman,

LEUKEMIA & LYMPHOMAno. 6 (2024): 800-807

Cited0Views0WOSBibtex

Chronic Myelomonocytic Leukemia (CMML) Presenting with Numb Chin Syndrome and Intractable Headache (P6-5.029)

Saori Haigo, Rumyar Ardakani, Zenggang Pan,Daniel Pollyea, Daniel Pastula, Amanda Piquet

Neurology（2024）

Cited0Views0Bibtex

Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial

Marina Y. Konopleva,Monique Dail,Naval G. Daver,Jacqueline S. Garcia,Brian A. Jonas,Karen W.L. Yee,Kevin R. Kelly, Norbert Vey,Sarit Assouline,Gail J. Roboz,Stefania Paolini,Daniel A. Pollyea,

Clinical Lymphoma Myeloma and Leukemia (2024)

Cited0Views0WOSBibtex

Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial

Marina Y Konopleva, Monique Dail, Naval G Daver, Jacqueline S Garcia, Brian A Jonas, Karen W L Yee, Kevin R Kelly, Norbert Vey, Sarit Assouline, Gail J Roboz, Stefania Paolini,Daniel A Pollyea,

Clinical lymphoma, myeloma & leukemiano. 6 (2024): 364-374

Cited0Views0WOSBibtex

POSTER: AML-219 Multi-Gene Molecular MRD by Digital PCR is Prognostic of Outcomes in AML Treated With Venetoclax/Azacitidine

Amanda Winters,Mohd Minhajuddin,Brett Stevens,Ajay Major,Nicholas Miltgen,Ji Yuan,Amy Treece, John Gutman,Craig Jordan,Daniel Pollyea

Clinical Lymphoma, Myeloma & Leukemia (2023): S157-S279

Cited0Views0Bibtex

Is Acute Myeloid Leukemia With Monocytic Features a Separate Entity

Daniel A. Pollyea

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023): S75-S76

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn